We are live on
!
Find out more
FA
Forefront Analytics Portfolio holdings
AUM
$92M
1-Year Est. Return
25.18%
This Fund
S&P 500
This Quarter
Est. Return
-4.95%
1 Year Est. Return
+25.18%
3 Year Est. Return
+50.89%
5 Year Est. Return
+36.12%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$1.04M
(+0.59%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
5.99%
Top 10 Holdings %
Top 10 Hldgs %
61.87%
Holding
71
New
6
Increased
37
Reduced
21
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northern Trust STOXX Global ESG Select ETF
ESGG
|
+$8.11M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.61M |
| 4 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$847K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$835K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$1.57M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.16M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.13M |
| 4 |
iShares ESG Aware MSCI EAFE ETF
ESGD
|
+$475K |
| 5 |
Invesco S&P Global Water Index ETF
CGW
|
+$461K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.9% |
| 2 | Healthcare | 1.15% |
| 3 | Technology | 0.43% |
| 4 | Financials | 0.29% |
| 5 | Industrials | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Regeneron Pharmaceuticals
REGN
$85.2B
| $241K | 0.14% |
293
-48
| -14% | -$37.7K |
|
52
Incyte
INCY
$25.7B
| $204K | 0.12% |
3,538
+5
| +0.1% | +$315 |
|
|
ORTX
53
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $110K | 0.06% |
+14,183
| New | +$76.8K |
|
54
Zura Bio
ZURA
$597M
| $95.5K | 0.05% |
+14,464
| New | +$96.7K |
|
|
FUSN
55
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $87.6K | 0.05% |
33,685
+13,610
| +68% | +$43.6K |
|
|
MREO
56
Mereo BioPharma
MREO
$39.9M
| $84.7K | 0.05% |
65,649
-17,100
| -21% | -$22.7K |
|
57
Jasper Therapeutics
JSPR
$23.6M
| $77.6K | 0.04% |
11,079
+4,142
| +60% | +$50.5K |
|
58
Annexon
ANNX
$923M
| $74.8K | 0.04% |
31,680
+4,890
| +18% | +$14.8K |
|
|
ACHL
59
DELISTED
Achilles Therapeutics
ACHL
| $71.1K | 0.04% |
78,169
+3,400
| +5% | +$3.23K |
|
60
ALX Oncology
ALXO
$278M
| $66.1K | 0.04% |
+13,769
| New | +$74.7K |
|
61
CytomX Therapeutics
CTMX
$808M
| $63.8K | 0.04% |
49,421
-175
| -0.4% | -$276 |
|
62
Geron
GERN
$1.01B
| $61.7K | 0.04% |
29,116
+14,225
| +96% | +$38.6K |
|
|
PSTX
63
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $59.4K | 0.03% |
24,969
-1,650
| -6% | -$3.46K |
|
64
Nkarta
NKTX
$209M
| $55.1K | 0.03% |
39,657
+29,290
| +283% | +$55.6K |
|
|
KRON
65
DELISTED
Kronos Bio
KRON
| $52K | 0.03% |
39,968
+900
| +2% | +$1.45K |
|
|
THRX
66
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $47.5K | 0.03% |
+17,672
| New | +$69.3K |
|
|
LONA
67
LeonaBio Inc
LONA
$71.2M
| $42K | 0.02% |
2,081
| – | – |
|
|
68
Invesco S&P Global Water Index ETF
CGW
$1.05B
| – | – |
-8,964
| Closed | -$461K |
|
69
iShares ESG Aware MSCI EM ETF
ESGE
$7.1B
| – | – |
-8,300
| Closed | -$263K |
|
70
Medtronic
MDT
$121B
| – | – |
-2,431
| Closed | -$214K |
|
71
Thermo Fisher Scientific
TMO
$227B
| – | – |
-427
| Closed | -$223K |
|
Similar funds
VI
GBA
PBCM
HI
DCA
SWP
SAM
Forefront Analytics's Q3 2023 Portfolio in Review
As of Q3 2023, Forefront Analytics held 71 positions worth $176M, up 0.59% from $175M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Forefront Analytics deployed $10.6M of net new capital in Q3 2023, opening 6 new positions and adding to 37 existing holdings. Its largest new stake was Northern Trust STOXX Global ESG Select ETF: 57,889 shares worth $7.81M.
By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, up from 98% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $1.57M trimmed.
- Forefront Analytics's largest Q3 2023 buy was Northern Trust STOXX Global ESG Select ETF: 57,889 shares worth $7.81M.
- Forefront Analytics added most to Vanguard FTSE Developed Markets ETF in Q3 2023, an estimated $1.69M increase.
- Forefront Analytics's biggest Q3 2023 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $1.57M.
- Forefront Analytics fully exited Invesco S&P Global Water Index ETF in Q3 2023, selling an estimated $461K.
- Forefront Analytics's ten largest holdings make up 62% of its $176M portfolio in Q3 2023.
- Forefront Analytics opened 6 new positions and closed 4 in Q3 2023.
- Forefront Analytics's portfolio value rose 0.59% quarter-over-quarter to $176M.
Based on Forefront Analytics's 13F filing for Q3 2023, filed 8 Nov 2023.